Clinical Trial Update: Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

View source ↗

Summary

This ongoing clinical trial aims to develop biomarkers to measure plexiform tumor burden in patients with neurofibromatosis type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Neurofibromatosis 1, NF1 | Status: ENROLLING_BY_INVITATION